Vivani Medical (id:5808 VANI)
1.34 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 12:45:19 PM)
Exchange closed, opens in 1 day 20 hours
About Vivani Medical
Market Capitalization 76.41M
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
Headquarters (address) |
1350 South Loop Road Alameda 94502 CA United States |
Phone | 415 506 8462 |
Website | https://www.vivani.com |
Employees | 36 |
Sector | Healthcare |
Industry | Biotechnology |
Ticker | VANI |
Exchange | NASDAQ Stock Exchange |
Currency | USD |
52 week range | 0.840 - 7.80 |
Market Capitalization | 76.41M |
P/E trailing | -2.68 |
P/E forward | -2.30 |
Price/Book | 3.17 |
Beta | 3.52 |
EPS | -0.430 |
EPS United States (ID:6, base:3399) | 24.27 |